← Eichor
Condition: Recurrent Prostate Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Prostate Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NA · 5 location(s) · Palette Life Sciences, Inc. · NCT06496256PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Phase 2 · 1 location(s) · Hoag Memorial Hospital Presbyterian · NCT04700332MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Phase N/A · 1 location(s) · Urological Research Network, LLC · NCT05241236Focal Radiotherapy for Previously Treated Prostate Cancer Patients
NA · 1 location(s) · Royal North Shore Hospital · NCT03073278PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 · 1 location(s) · University of Nebraska · NCT07234981Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cance
NA · 1 location(s) · Sinotau Pharmaceutical Group · NCT07115277Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas
NA · 2 location(s) · University Health Network, Toronto · NCT05328505Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
NA · 1 location(s) · Martini-Klinik am UKE GmbH · NCT04271579An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · 147 location(s) · Novartis Pharmaceuticals · NCT05939414Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · 342 location(s) · ECOG-ACRIN Cancer Research Group · NCT04423211Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT05597852Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20
NA · 4 location(s) · CHU de Quebec-Universite Laval · NCT07483658Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Phase 3 · 1 location(s) · HTA Co., Ltd. · NCT06754085Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
NA · 13 location(s) · Jules Bordet Institute · NCT06523634Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
Phase 3 · 17 location(s) · Instituto de Investigación en Oncología Radioterápica - Fund · NCT05781217A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Phase 1 · 38 location(s) · Eli Lilly and Company · NCT06465069Salvage HDR for Locally Recurrent Prostate Cancer
NA · 1 location(s) · Aarhus University Hospital · NCT04231006Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
Phase 3 · 5 location(s) · Stefan Carlsson · NCT04794777Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
NA · 3 location(s) · Lund University Hospital · NCT04858880Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06305832Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT06769425Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Phase 3 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05352178Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · 3 location(s) · University of Erlangen-Nürnberg Medical School · NCT07131956Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NA · 2 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06046131Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06657131PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914Partial Prostate Salvage High Dose Rate Brachytherapy
NA · 1 location(s) · British Columbia Cancer Agency · NCT03246802Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
NA · 1 location(s) · University Health Network, Toronto · NCT06508567
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.